ReviewFrontiers in neurology2026

Should ApoE4 gene editing therapy be approached with caution when AD is accompanied by retinal neurodegenerative diseases?

Yi Wenhua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.